J. McGough

Publications179
h-index66
Citations14,824
Highly Influential Citations750
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Faraone
  • 1,332 Publications, 113,311 Citations
  • J. Biederman
  • 1,140 Publications, 108,185 Citations
  • B. Neale
  • 426 Publications, 69,265 Citations
  • J. McCracken
  • 344 Publications, 21,968 Citations
  • Publications
  • Influence
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Most psychiatric disorders are moderately to highly heritable. The degree to which genetic variation is unique to individual disorders or shared across disorders is unclear. To examine shared genetic… Expand
  • 1,587
  • 43
  • PDF
Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.
OBJECTIVE Patterns of psychiatric comorbidity were assessed in adults with and without attention deficit hyperactivity disorder (ADHD) identified through a genetic study of families containing… Expand
  • 372
  • 29
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
OBJECTIVE The Preschool ADHD Treatment Study (PATS) was a NIMH-funded, six-center, randomized, controlled trial to determine the efficacy and safety of immediate-release methylphenidate (MPH-IR),… Expand
  • 355
  • 27
  • PDF
A genomewide scan for loci involved in attention-deficit/hyperactivity disorder.
Attention deficit/hyperactivity disorder (ADHD) is a common heritable disorder with a childhood onset. Molecular genetic studies of ADHD have previously focused on examining the roles of specific… Expand
  • 304
  • 27
  • PDF
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose,…
BACKGROUND Lisdexamfetamme dimesylate (LDX) is a therapeutically inactive amphetamine prodrug. It was developed with the goal of providing an extended duration of effect that is consistent throughout… Expand
  • 192
  • 27
Risperidone in children with autism and serious behavioral problems.
BACKGROUND Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional antipsychotic medications in the treatment of adults with… Expand
  • 930
  • 26
Diagnostic controversies in adult attention deficit hyperactivity disorder.
OBJECTIVE While it is increasingly recognized that attention deficit hyperactivity disorder (ADHD) persists into adulthood, there is no consensus on diagnostic criteria for adult ADHD. In this… Expand
  • 391
  • 24
  • PDF
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder.
OBJECTIVE Although twin and family studies have shown attention-deficit/hyperactivity disorder (ADHD) to be highly heritable, genetic variants influencing the trait at a genome-wide significant level… Expand
  • 413
  • 23
  • PDF
Analysis of shared heritability in common disorders of the brain
Brainstorming diseases Consistent classification of neuropsychiatric diseases is problematic because it can lead to misunderstanding of etiology. The Brainstorm Consortium examined multiple… Expand
  • 554
  • 18
  • PDF
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
OBJECTIVE Short-term, controlled studies of extended-release guanfacine (GXR), a selective alpha(2A)-adrenoreceptor agonist, demonstrate efficacy in treating attention-deficit/hyperactivity disorder… Expand
  • 131
  • 16